Regulation News
Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.
AT&T Shares Slide Amid California Regulatory Clash Over Copper Network Phase-Out
AT&T shares dropped 5.5% to $22.01 this week as California regulators intensify opposition to the company's plan to phase out legacy copper-wire phone service, raising concerns over cost savings and future cash flow.
NYSEG Completes New York Transmission Line Early, Saving $2M for Ratepayers
Avangrid's NYSEG finished a 12.8-mile transmission upgrade in western New York three months early and $2 million under budget, providing a cost-control win as regulators review rates.
Entergy's Grid Upgrades Tested as Arthur's Remnants Bring Flood Risk
Entergy Louisiana's $13.5 million grid-hardening project in St. Bernard Parish is tested by Arthur's remnants, potentially avoiding $24M in storm costs.
Rivian Cuts Jobs, R2 Launch Adds to Financial Strain
Rivian is cutting hundreds of jobs, less than 2% of its workforce, to reduce costs after launching the R2 SUV. Shares closed up 2% as investors weigh cost cuts against margin pressures.
Invenergy Accepts $765M Payout to Exit Offshore Wind Leases
Invenergy will get $765 million to terminate four offshore wind leases, with funds redirected to natural gas and geothermal, as the administration's buyback program nears $2.6 billion.
U.S. DOT Closes Delta Probe Without Penalties, Easing Regulatory Pressure
The DOT closed its probe into Delta's 2024 CrowdStrike outage without penalties, removing a major regulatory risk for the airline.
Coupang Stock Jumps on $410M Privacy Fine Disclosure, Analyst Upgrade
Coupang shares surged 8.3% to $19.53 after disclosing $410 million in Korean privacy fines and receiving an Outperform rating from CLSA with a $24 target.
Boeing 737 MAX 7 and MAX 10 Near Final Regulatory Clearance
Boeing's 737 MAX 7 and MAX 10 are in the final stage of U.S. and European regulatory approval, with only documentation left. Certification is crucial for Boeing's cash recovery and airline customers.
FDA Greenlights uniQure's Accelerated Approval Path for Huntington's Gene Therapy
uniQure shares surged 78% premarket after the FDA agreed to accept three-year Phase I/II data as the basis for an accelerated approval filing for AMT-130 in Huntington's disease, reviving the near-term U.S. path for the potential first disease-modifying treatment.
Ford Stock Dips on China Software Rule Uncertainty
Ford shares slipped 1.1% to $14.61 after Reuters reported the company needs U.S. approval to keep importing China-built Lincoln Nautilus SUVs due to new connected-vehicle rules.
Moderna Shares Surge on Positive FDA Staff Review for mRNA Flu Vaccine
Moderna shares surged nearly 10% to $57.19 after FDA staff said data on its mRNA flu shot may support effectiveness in adults 65+, lowering regulatory risk ahead of a key advisory panel vote.
Snap Shares Surge on Tech Rally Ahead of AR Event, UK Regulations Loom
Snap shares surged 8.56% to $5.71 amid a tech rally, as investors await CEO Evan Spiegel's Specs AR glasses keynote. A UK plan to ban under-16s from social media introduces fresh regulatory risk.